Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.
Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K.
Hampel H, et al. Among authors: bokde al.
Nat Rev Drug Discov. 2010 Jul;9(7):560-74. doi: 10.1038/nrd3115.
Nat Rev Drug Discov. 2010.
PMID: 20592748
Review.